Your browser doesn't support javascript.
loading
Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma.
Kang, Junwei; Zheng, Zhiying; Li, Xian; Huang, Tian; Rong, Dawei; Liu, Xinyang; Qin, Miaomiao; Wang, Yuliang; Kong, Xiangyi; Song, Jinhua; Lv, Chengyu; Pan, Xiongxiong.
Afiliação
  • Kang J; Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zheng Z; Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Li X; Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Huang T; Hepatobiliary Center, Key Laboratory of Liver Transplantation, NHC Key Laboratory of Living Donor Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Chinese Academy of Medical Sciences, Nanjing, China.
  • Rong D; Hepatobiliary Center, Key Laboratory of Liver Transplantation, NHC Key Laboratory of Living Donor Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Chinese Academy of Medical Sciences, Nanjing, China.
  • Liu X; Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Qin M; Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang Y; Basic Medical School, Nanjing Medical University, Nanjing, China.
  • Kong X; Hepatobiliary Center, Key Laboratory of Liver Transplantation, NHC Key Laboratory of Living Donor Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Chinese Academy of Medical Sciences, Nanjing, China.
  • Song J; Hepatobiliary Center, Key Laboratory of Liver Transplantation, NHC Key Laboratory of Living Donor Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Chinese Academy of Medical Sciences, Nanjing, China. jinhuasongnanj@163.com.
  • Lv C; Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. lcy_1234@aliyun.com.
  • Pan X; Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. xiongxiong@njmu.edu.cn.
Cancer Cell Int ; 22(1): 312, 2022 Oct 12.
Article em En | MEDLINE | ID: mdl-36224624

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article